No Data
Puma Posts Lower Earnings After Sales Suffer Currency Headwind
By Pierre Bertrand Puma reported a decline in first-quarter earnings after sales were hit by unfavorable currency effects. The German sporting-goods company said it made 87.3 million euros ($93.9 mi
Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Express News | HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target
Puma Biotechnology Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 43.44% HC Wainwright & Co. → $7 Reiterates Buy → Buy 03/01/2024 43.44% HC Wainwright & Co. $8 →
Earnings Call Summary | Puma Biotechnology(PBYI.US) Q1 2024 Earnings Conference
The following is a summary of the Puma Biotechnology, Inc. (PBYI) Q1 2024 Earnings Call Transcript:Financial Performance:Puma Biotechnology reported a total revenue of $43.8 million for Q1 2024, which
loading...